IP Library Granted Patent US 11,208,673
Granted Patent B2
US 11,208,673 · App. 16/213,671 · Granted Dec 28, 2021

Microorganisms and methods for the biosynthesis of adipate, hexamethylenediamine and 6-aminocaproic acid

Inventors: Mark J. Burk (San Diego, CA); Anthony P. Burgard (Elizabeth, PA); Robin E. Osterhout (San Diego, CA); Priti Pharkya (San Diego, CA)
Assignee: Genomatica, Inc.
C12P17/10C12N1/38C12N15/52C12P7/40C12P7/44C12P13/001C12P13/005C12P13/02C12P17/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,208,673
App. No.
16/213,671
Granted
Dec 28, 2021
Kind
B2
Abstract

The invention provides a non-naturally occurring microbial organism having a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The invention additionally provides a method for producing 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid. The method can include culturing a 6-aminocaproic acid, caprolactam or hexametheylenediamine producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid.

Claims (14)

1. A non-naturally occurring microbial organism, comprising a microbial organism having a 6-aminocaproic acid (6-ACA) pathway comprising at least two exogenous nucleic acids encoding 6-ACA pathway enzymes expressed in a sufficient amount to produce 6-ACA from glutamate, said 6-ACA pathway enzymes comprising: a glutamyl-CoA transferase or a glutamyl-CoA ligase; a beta-ketothiolase; an 3-oxo-6-aminopimeloyl-CoA oxidoreductase; a 3-hydroxy-6-aminopimeloyl-CoA dehydratase; a 6-amino-7-carboxyhept-2-enoyl-CoA reductase; 6-aminopimeloyl-CoA hydrolase, transferase and/or ligase; and a 2-aminopimelate decarboxylase.

2. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises a set of exogenous nucleic acids encoding 6-ACA pathway enzymes expressed in a sufficient amount to produce 6-ACA, said set of exogenous nucleic acids comprising: a glutamyl-CoA transferase or a glutamyl-CoA ligase; a beta-ketothiolase; a 3-oxo-6-aminopimeloyl-CoA oxidoreductase; a 3-hydroxy-6-aminopimeloyl-CoA dehydratase; a 6-amino-7-carboxyhept-2-enoyl-CoA reductase; 6-aminopimeloyl-CoA hydrolase, transferase and/or ligase; and a 2-aminopimelate decarboxylase.

3. The non-naturally occurring microbial organism of claim 1 , wherein said 6-ACA pathway comprises at least three exogenous nucleic acids.

4. The non-naturally occurring microbial organism of claim 1 , wherein said exogenous nucleic acid is a heterologous nucleic acid.

5. The non-naturally occurring microbial organism of claim 1 , wherein said non-naturally occurring microbial organism is in culture medium, wherein said culture medium is in an atmosphere of less than 1% oxygen or comprises dissolved oxygen in an amount that is less than 10% of saturation.

6. The non-naturally occurring microbial organism of claim 1 , wherein said 6-ACA pathway comprises at least four exogenous nucleic acids.

7. The non-naturally occurring microbial organism of claim 1 , wherein said 6-ACA pathway comprises at least five exogenous nucleic acids.

8. The non-naturally occurring microbial organism of claim 1 , wherein said 6-ACA pathway comprises at least six exogenous nucleic acids.

9. The non-naturally occurring microbial organism of claim 1 , wherein said 6-ACA pathway comprises at least seven exogenous nucleic acids.

10. The non-naturally occurring microbial organism of claim 1 , wherein said 6-ACA pathway comprises at least eight exogenous nucleic acids.

11. A method for producing 6-aminocaproic acid (6-ACA), comprising culturing a non-naturally occurring microbial organism of claim 5 under conditions and for a sufficient period of time to produce 6-ACA.

12. The non-naturally occurring microbial organism of claim 1 , part (iv), further comprising a 2-amino-7-oxosubarate pathway comprising at least one exogenous nucleic acid encoding a 2-amino-7-oxosubarate pathway enzyme expressed in a sufficient amount to produce 2-amino-7-oxosubarate, said 2-amino-7-oxosubarate pathway comprising a 2-amino-5-hydroxy-7-oxosubarate aldolase, a 2-amino-5-hydroxy-7-oxosubarate dehydratase, or a 2-amino-5-ene-7-oxosubarate reductase.

13. The non-naturally occurring microbial organism of claim 2 , part (v), further comprising a 2-amino-7-oxosubarate pathway comprising a second set of exogenous nucleic acids encoding 2-amino-7-oxosubarate pathway enzymes expressed in a sufficient amount to produce 2-amino-7-oxosubarate, said second set of exogenous nucleic acids encoding a 2-amino-5-hydroxy-7-oxosubarate aldolase; a 2-amino-5-hydroxy-7-oxosubarate dehydratase; and a 2-amino-5-ene-7-oxosubarate reductase.

14. A method for producing 6-aminocaproic acid (6-ACA), comprising culturing a non-naturally occurring microbial organism of claim 1 under conditions and for a sufficient period of time to produce 6-ACA.

Assignments (3)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →